MedPath

KAZM Pharmaceuticals Inc.

🇨🇦Canada
Ownership
Private
Established
1982-01-01
Employees
-
Market Cap
-
Website
http://www.kazmradio.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty

Phase 3
Recruiting
Conditions
Postsurgical Pain
Interventions
Drug: Multiprofen-CC™ plus standard treatment
Other: Placebo plus standard treatment
First Posted Date
2024-01-12
Last Posted Date
2024-11-14
Lead Sponsor
KAZM Pharmaceuticals Inc.
Target Recruit Count
288
Registration Number
NCT06202989
Locations
🇨🇦

St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada

🇨🇦

Oakville Trafalgar Memorial Hospital, Oakville, Ontario, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.